Hyperemesis gravidarum in premarital pregnancy: scoping review

Nurhidaya Fitria; Cesa Septiana Pratiwi; Menik sri daryanti

doi:10.31101/ijhst.v3i3.1981

Authors

Nurhidaya Fitria Universitas 'Aisyiyah Yogyakarta, Indonesia
Cesa Septiana Pratiwi Universitas â€˜Aisyiyah Yogyakarta, Indonesia
Menik sri daryanti Universitas â€˜Aisyiyah Yogyakarta, Indonesia

DOI:

https://doi.org/10.31101/ijhst.v3i3.1981

Keywords:

hyperemesis gravidarum, premarital, pregnant

Abstract

Hyperemesis gravidarum is the main cause of death, currently the hyperemesis gravidarum is no longer the main cause of maternal mortality, however the hyperemesis gravidarum is still the main cause of maternal mordibility. The cause of hyperemesis gravidarum is not yet known with certainty, with an incidence of 2/1000 pregnancies. Several influences have factors, including predisposing factors (primigravida, hydatidiform mole, and multiple pregnancy). Organic factors (allergies, entry of chorial villi in the circulation, metabolic changes due to pregnancy, and the maternal resistance is decreased). Psychological factors (age, household, job loss, fear). The method used through five stages, namely identifying scoping review questions with the PEOT framework (Population, Exposure, Outcome, and Thema), identifying articles using relevant databases (PubMed, Ebsco, Wiley, Science Direct) and gray literature (Google Scholar). by using keywords, article selection, data charting, compiling, summarizing and reporting results. Five articles had the highest and lowest scores. Four themes emerged as a result of the scoping review, it consisted of the prevalence, incidence, degree and management of hyperemesis gravidarum in premarital pregnancy.Â Â

References

Aleyasin, A., Saffarieh, E., Torkamandi, H., Hanafi, S., Sadeghi, F., Mahdavi, A., Bahmaei, F., & Javadi, M. (2016). Comparison of efficacy of granisetron and promethazine in control of hyperemesis gravidarum. Journal of Obstetrics and Gynecology of India, 66(6), 409â€“414. https://doi.org/10.1007/s13224-015-0709-6.

Birkeland, E., Stokke, G., Tangvik, R. J., Torkildsen, E. A., Boateng, J., Wollen, A. L., Albrechtsen, S., Flaatten, H., & Trovik, J. (2015). Norwegian PUQE (pregnancy-unique quantification of emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: A prospective cohort validation study. PLoS ONE, 10(4), 1â€“15. https://doi.org/10.1371/journal.pone.0119962

Bottomley, C., & Bourne, T. (2012). Management strategies for hyperemesis. Best Practice and Research: Clinical Obstetrics and Gynaecology, 23(4), 549â€“564. https://doi.org/10.1016/j.bpobgyn.2008.12.012

Cooper. (2019). Hyperemesis gravidarum pada ibu hamil. 5â€“10.

Goossens, J., Van Den Branden, Y., Van Der Sluys, L., Delbaere, I., Van Hecke, A., Verhaeghe, S., & Beeckman, D. (2016). The prevalence of unplanned pregnancy ending in birth, associated factors, and health outcomes. Human Reproduction, 31(12), 2821â€“2833. https://doi.org/10.1093/humrep/dew266

Havnen, G. C., Truong, M. B. T., Do, M. L. H., Heitmann, K., Holst, L., & Nordeng, H. (2019). Womenâ€™s perspectives on the management and consequences of hyperemesis gravidarumâ€“a descriptive interview study. Scandinavian Journal of Primary Health Care, 37(1), 30â€“40. https://doi.org/10.1080/02813432.2019.1569424

James, W. H. (2012). The sex ratio of pregnancies complicated by hospitalisation for hyperemesis gravidarum [3]. BJOG: An International Journal of Obstetrics and Gynaecology, 111(6), 636. https://doi.org/10.1111/j.1471-0528.2004.00145.x

Kloter, E., Gerstenberg, G., Berenyi, T., Gollmer, B., FlÃ¼ger, C., Klein, U., Eberhard, J., Kuck, A., & Wolf, U. (2019). Treatment of hyperemesis gravidarum with anthroposophic complex therapy in 3 case reports. Complementary Therapies in Medicine, 44, 14â€“17. https://doi.org/10.1016/j.ctim.2019.02.011

Koudijs, H. M., Savitri, A. I., Browne, J. L., Amelia, D., Baharuddin, M., Grobbee, D. E., & Uiterwaal, C. S. P. M. (2016). Hyperemesis gravidarum and placental dysfunction disorders. BMC Pregnancy and Childbirth, 1â€“9. https://doi.org/10.1186/s12884-016-1174-7

London, V., Grube, S., Sherer, D. M., & Abulafia, O. (2017). Hyperemesis gravidarum: A review of recent literature. Pharmacology, 100(3â€“4), 161â€“171. https://doi.org/10.1159/000477853

Mekonnen, A. G., Amogne, F. K., & Worku Kassahun, C. (2018). Risk factors of hyperemesis gravidarum among pregnant women in Bale Zone Hospitals, Southeast Ethiopia: unmatched case-control study. Clinics in Mother and Child Health, 15(3). https://doi.org/10.4172/2090-7214.1000300

Romero-Gutierrez, G., Cruz-Arvizu, V. H., Regalado-Cedillo, C. A., & Ponce-Ponce de Leon, A. L. (2012). Prevalence of violence against pregnant women and associated maternal and neonatal complications in Leon, Mexico. Midwifery, 27(5), 750â€“753. https://doi.org/10.1016/j.midw.2010.06.015

Rudiyanti, R. (2019). Hubungan usia, paritas, pekerjaan dan stress dengan emesis gravidarum di Kota Bandar Lampung. 15(1), 7â€“18.

Tan, P. C., Vani, S., Lim, B. K., & Omar, S. Z. (2012). Anxiety and depression in hyperemesis gravidarum: prevalence, risk factors and correlation with clinical severity. European Journal of Obstetrics and Gynecology and Reproductive Biology, 149(2), 153â€“158. https://doi.org/10.1016/j.ejogrb.2009.12.031

Temming, L., Franco, A., Istwan, N., Rhea, D., Desch, C., Stanziano, G., & Joy, S. (2014). Adverse pregnancy outcomes in women with nausea and vomiting of pregnancy. Journal of Maternal-Fetal and Neonatal Medicine, 27(1), 84â€“88. https://doi.org/10.3109/14767058.2013.806473